Caroline Stubbs, PharmD (c), Thy Ton-Morrison PharmD (c), Omar Alkedeh PharmD (c), Jonathan Huynh PharmD (c), Nikhil A. Sangave, PharmD, BCACP

Temelimab is a recombinant humanized IgG4 monoclonal antibody that blocks the HERV-W protein, which is associated with the pathology of autoimmune disorders, such as multiple sclerosis and type 1 diabetes.